ULURU Inc. (NYSEMKT:ULU)

CAPS Rating: No stars

The Company is an emerging pharmaceutical company focused on advancing topical drug delivery and engaged in the development of novel topically applied therapeutics based primarily on the adaptation of existing therapeutic agents.

Results 1 - 1 of 1

Recs

0
Member Avatar TMFMattyA (99.72) Submitted: 3/26/2008 4:16:40 PM : Underperform Start Price: $2.50 ULU Score: +144.64

I should give this stock a thumbs-down based on its name alone. Try saying "Uluru" 10 times really fast. Ah, never mind. I'll settle for the fact that the company will likely never make money, will continue to dilute shareholders with monster share offerings, while rewarding managers with high salaries.

Results 1 - 1 of 1

Featured Broker Partners


Advertisement